Photoallergic Potential of 6% Bemotrizinol

Clinical trial NCT05254912 · COMPLETED

Trial details

NCT number: NCT05254912
Sponsor: dsm-firmenich Switzerland AG
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Photoallergic Response

Start date: 2022-03-07
Primary completion: 2022-04-22
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.